Consensus guideline for the management of patients with appendiceal tumors, part 2: Appendiceal tumors with peritoneal involvement
- PMID: 40558065
- DOI: 10.1002/cncr.35874
Consensus guideline for the management of patients with appendiceal tumors, part 2: Appendiceal tumors with peritoneal involvement
Abstract
Background: Appendiceal tumors comprise a heterogeneous group of tumors that frequently disseminate to the peritoneum. Management of appendiceal tumors is lacking high-quality data given their rarity and heterogeneity. In general, appendiceal tumor treatment is extrapolated in part from colorectal cancer or pooled studies, without definitive evidence of disease-specific benefit. Many practices are controversial and vary widely between institutions. A national consensus update of best management practices for appendiceal malignancies was performed to better standardize care. Herein, the authors present recommendations for the management of appendiceal tumors with peritoneal involvement.
Methods: As previously described, modified Delphi consensus was performed to update the previous 2018 Chicago Consensus guideline. Recommendations were supported by using rapid systematic reviews of key issues in surgical and systemic therapy. Key pathology concepts and recommendations were synthesized in collaboration with content experts.
Results: A consensus-based pathway was generated for any type of non-neuroendocrine appendiceal tumor with peritoneal involvement. The first round of Delphi consensus included 138 participants, of whom 133 (96%) participated in the second round, and greater than 90% consensus was achieved for all pathway blocks. Key items included recommending evaluation for cytoreduction to most patients with low-grade peritoneal disease who are surgical candidates and to many patients with high-grade disease, as well as timing of systemic chemotherapy and surveillance protocols. Common pitfalls in pathologic classification and their clinical implications are also presented.
Conclusions: These consensus recommendations provide guidance regarding the management of appendiceal tumors with peritoneal involvement, including a review of current evidence in the management of recurrent and unresectable disease.
Keywords: appendiceal malignancies; cytoreductive surgical procedures, guidelines; peritoneal neoplasms; peritoneal surface malignancies.
© 2025 American Cancer Society.
References
REFERENCES
-
- Govaerts K, Lurvink RJ, De Hingh IHJT, et al. Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol. 2021;47(1):11‐35. doi:10.1016/j.ejso.2020.02.012
-
- Glasgow SC, Gaertner W, Stewart D, et al. The American Society of Colon and Rectal Surgeons, clinical practice guidelines for the management of appendiceal neoplasms. Dis Colon Rectum. 2019;62(12):1425‐1438. doi:10.1097/DCR.0000000000001530
-
- Shen JP, Yousef AM, Zeineddine FA, et al. Efficacy of systemic chemotherapy in patients with low‐grade mucinous appendiceal adenocarcinoma: a randomized crossover trial. JAMA Netw Open. 2023;6(6):e2313131. doi:10.1001/jamanetworkopen.2023.16161
-
- Hoehn RS, Rieser CJ, Choudry MH, Melnitchouk N, Hechtman J, Bahary N. Current management of appendiceal neoplasms. Am Soc Clin Oncol Educ Book. 2021;41:118‐132. doi:10.1200/EDBK_321009
-
- Chicago Consensus Working Group. The Chicago Consensus on peritoneal surface malignancies: management of appendiceal neoplasms. Ann Surg Oncol. 2020;27(6):1753‐1760. doi:10.1245/s10434‐020‐08316‐w
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
